Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2017 | 2 |
2018 | 1 |
2019 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Editorial: tailoring mycophenolate mofetil rescue therapy for success in autoimmune hepatitis-authors' reply.
Aliment Pharmacol Ther. 2019 Jun;49(11):1450-1451. doi: 10.1111/apt.15276.
Aliment Pharmacol Ther. 2019.
PMID: 31074895
No abstract available.
Sofosbuvir and daclatasvir therapy in patients with hepatitis C-related advanced decompensated liver disease (MELD ≥ 15).
McCaughan GW, Thwaites PA, Roberts SK, Strasser SI, Mitchell J, Morales B, Mason S, Gow P, Wigg A, Tallis C, Jeffrey G, George J, Thompson AJ, Parker FC, Angus PW; Australian Liver Association Clinical Research Network.
McCaughan GW, et al.
Aliment Pharmacol Ther. 2018 Feb;47(3):401-411. doi: 10.1111/apt.14404. Epub 2017 Dec 5.
Aliment Pharmacol Ther. 2018.
PMID: 29205432
Item in Clipboard
Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies.
Roberts SK, Mitchell J, Leung R, Booth D, Bollipo S, Ostapowicz G, Sloss A, McCaughan GW, Dore GJ, Thompson A, Crawford DH, Sievert W, Weltman M, Cheng W, George J; Australian Liver Association Clinical Research Network.
Roberts SK, et al.
J Gastroenterol Hepatol. 2014 Jan;29(1):179-84. doi: 10.1111/jgh.12424.
J Gastroenterol Hepatol. 2014.
PMID: 24219707
Item in Clipboard
Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study.
Lubel J, Strasser S, Stuart KA, Dore G, Thompson A, Pianko S, Bollipo S, Mitchell JL, Fragomeli V, Jones T, Chivers S, Gow P, Iser D, Levy M, Tse E, Gazzola A, Cheng W, Nazareth S, Galhenage S, Wade A, Weltman M, Wigg A, MacQuillan G, Sasadeusz J, George J, Zekry A, Roberts SK; Australian Liver Association Clinical Research Network (ALA CRN).
Lubel J, et al.
Antivir Ther. 2017;22(8):699-710. doi: 10.3851/IMP3168.
Antivir Ther. 2017.
PMID: 28422043
Item in Clipboard
Letter: elderly AIH patients-an important subgroup. Authors' reply.
Nicoll AJ, Roberts SK, Mitchell J, Strasser SI, McCaughan GW; Australian Liver Association Clinical Research Network.
Nicoll AJ, et al.
Aliment Pharmacol Ther. 2019 Sep;50(5):615. doi: 10.1111/apt.15426.
Aliment Pharmacol Ther. 2019.
PMID: 31414532
No abstract available.
Item in Clipboard
Cite
Cite